The AJMC® Cholangiocarcinoma compendium is a comprehensive resource for clinical news and expert insights about this rare cancer of the bile duct.
Robotic Surgery Offers Potential New Strategy for Hilar Cholangiocarcinoma ResectionOctober 18th 2022
A new report consolidates existing research on hilar cholangiocarcinoma resection, but finds more work is needed to better evaluate the efficacy of robotic surgery in these patients.
Study Supports Comprehensive Genomic Profiling for Patients With Biliary Tract CancerSeptember 24th 2022
A small study suggests that comprehensive genomic profiling can help with clinical decision-making and predicting clinical outcomes in advanced biliary tract cancer, but further research is needed.
Case Report Describes Youngest Recorded Patient With Intrahepatic Sarcomatoid CholangiocarcinomaSeptember 24th 2022
The rare condition can easily be confused with hepatocellular carcinoma, but immunohistochemical studies can help accurately diagnose intrahepatic sarcomatoid cholangiocarcinoma.
Durvalumab With Chemo Wins FDA Approval in Treatment of Biliary Tract CancersSeptember 6th 2022
An estimated 1 in 4 patients treated with durvalumab and chemotherapy (gemcitabine plus cisplatin) was alive at 2 years compared with 1 in 10 treated with chemotherapy alone, with these results contributing to the FDA's approval of the first immunotherapy to treat these cancers.
Researchers From Spain Find Option to Detect FGFR2 Fusion in PlasmaJuly 2nd 2022
Vall d'Hebron Institute of Oncology, a research group from Barcelona, Spain, has presented a method to detect FGFR2 fusion in plasma, which they say is “especially relevant” since the arrival of pemigatinib to treat patients with recurrent intrahepatic cholangiocarcinoma (iCCA).